The role of gadolinium-DTPA in the evaluation of extracranial head and neck mass lesions.

Based on our experience with 28 patients, there is good evidence that gadolinium-enhanced MR will be useful in evaluation of skull base involvement, sinus involvement, or intracranial extension by neoplasms that involve the neck above the hard palate. This region has historically been a difficult area to image with any modality, because of the detailed anatomy and numerous important structures that traverse it. Gadolinium-enhanced MR should provide a valuable tool in the evaluation and management of these patients. The evidence that gadolinium is useful in staging of primary and nodal squamous cell carcinoma of the extracranial head and neck is less apparent. Areas where gadolinium may be helpful include size and extent of primary tumor and internal architecture of nodes that do not meet size criteria for malignant adenopathy. This is an area in which more experience is necessary, employing careful correlation with enhanced CT, unenhanced MR, and surgical specimens. Posttreatment follow-up of head and neck squamous cell lesions is a potential use for gadolinium, but this too is yet to be adequately studied. We have found that gadolinium enhancement provides no additional information important to the management of benign head and neck lesions over enhanced CT or unenhanced MR.

• Publication year

  1989

• Venue

  The Radiologic clinics of North America

• Publication date

  1989-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/s0033-8389(22)00872-7PMID 2919230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.

  1988cited by this paper
• MR imaging of the oropharynx and tongue: comparison of plain and Gd-DTPA studies.

  1988cited by this paper
• MR imaging of the nasopharynx and floor of the middle cranial fossa. Part I. Normal anatomy.

  1987cited by this paper
• MR imaging of the nasopharynx and floor of the middle cranial fossa. Part II. Malignant tumors.

  1987cited by this paper
• Benign extraaxial tumors: contrast enhancement with Gd-DTPA.

  1987cited by this paper
• Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors.

  1987cited by this paper
• Tumors of the parapharyngeal space and upper neck: MR imaging characteristics.

  1987cited by this paper
• Larynx and hypopharynx: MR imaging with surface coils.

  1986cited by this paper
• Tongue and oropharynx: findings on MR imaging.

  1986cited by this paper
• Applications of magnetic resonance imaging to the head and neck

  1986cited by this paper
• Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA.

  1986cited by this paper
• Neck neoplasms: MR imaging. Part I. Initial evaluation.

  1986cited by this paper
• Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.

  1986cited by this paper
• Gd-DTPA in clinical MR of the brain: 2. Extraaxial lesions and normal structures.

  1986cited by this paper
• Brain tumors: MR imaging with gadolinium-DTPA.

  1985cited by this paper
• The oral cavity and tongue: magnetic resonance imaging.

  1985cited by this paper
• Gadolinium‐DTPA as a Contrast Agent in MR Imaging—Theoretical Projections and Practical Observations

  1985cited by this paper
• Some physicochemical properties of the gadolinium-DTPA complex, a contrast agent for MRI.

  1984cited by this paper
• Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

  1984cited by this paper
• Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics.

  1984cited by this paper
• Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

  1984cited by this paper
• First use of GdDTPA/dimeglumine in man.

  1984cited by this paper
• Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.

  1984cited by this paper
• Magnetic resonance imaging of the nasopharynx.

  1984cited by this paper

• Overview of Diagnostic Imaging of the Head and Neck

  2010cites this paper
• Sinonasal Cavity, Nasopharynx, and Oropharynx

  2009cites this paper
• IRM de la filière naso-oro-pharyngée, de l'hypopharynx et des espaces profonds de la face : technique, résultats normaux et indications

  2008cites this paper
• Postirradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients

  2007cites this paper
• Diseases of the thyroid in childhood and adolescence: Imaging of the normal and affected thyroid in childhood

  2007cites this paper
• Diagnosis and treatment of the N0 neck in carcinomas of the upper aerodigestive tract: current status of diagnostic procedures

  2004cites this paper
• Posttreatment imaging of the nasopharynx.

  2002cites this paper
• Invasion of the skull base by carcinomas: histopathologically evidenced findings with CT and MRI

  2002cites this paper
• Oropharynx, oral cavity, floor of the mouth: CT and MRI.

  2000cites this paper
• Methods: MRT.

  2000cites this paper
• MRI in recurrent nasopharyngeal carcinoma

  1999cites this paper
• Invited. MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy

  1998cites this paper
• Nasopharyngeal carcinoma: dynamic MR imaging with gadolinium.

  1998cites this paper
• Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy.

  1997cites this paper
• Comparison of T2 weighted fat suppressed turbo spin echo and contrast enhanced T1 weighted spin echo MRI in nasopharyngeal carcinoma.

  1997cites this paper
• Nasopharyngeal carcinoma: MRI and CT assessment

  1997cites this paper
• Lingual Carcinoma

  1996cites this paper
• Imaging of the oropharynx and oral cavity

  1996cites this paper
• Usefulness of fat-suppression magnetic resonance imaging for oral and maxillofacial lesions.

  1996cites this paper
• Imaging of the oropharynx and oral cavity

  1996cites this paper
• Conspicuity of tumors of the head and neck on fat-suppressed MR images: T2-weighted fast-spin-echo versus contrast-enhanced T1-weighted conventional spin-echo sequences.

  1995cites this paper
• Pathologie tumorale bénigne et maligne du massif facial

  1995cites this paper
• [Postoperative MRI findings after cholesteatoma surgery].

  1995cites this paper
• The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients

  1995cites this paper
• Advances in Magnetic Resonance Imaging of the Head and Neck

  1994cites this paper
• Contrast enhancement in head and neck imaging.

  1994cites this paper
• The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer.

  1994cites this paper
• MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.

  1994cites this paper
• Supratentorial extraparenchymal and meningocerebral lesions

  1994cites this paper
• Multicenter trial of gadoteridol, a nonionic gadolinium chelate, in patients with suspected head and neck pathology.

  1993cites this paper
• Significance of MRI Changes after Surgery of the Skull Base

  1993cites this paper
• Use of gadolinium chelates in MR imaging of lesions of the extracranial head and neck

  1993cites this paper
• Magnetic resonance imaging of the head and neck.

  1993cites this paper
• MR imaging in the management of extracranial malignant tumors of the head and neck.

  1992cites this paper
• Development of Contrast Media for Magnetic Resonance Imaging

  1992cites this paper
• Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy

  1992cites this paper
• Complementary use of computed tomography and magnetic resonance imaging in assessing skull base lesions

  1992cites this paper
• Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology.

  1992cites this paper
• Magnetic resonance imaging in oncology.

  1992cites this paper
• Magnetic resonance imaging of extracranial head and neck tumours.

  1992cites this paper
• Gd-DTPA enhanced MRI for the oral and maxillofacial cystic lesion

  1992cites this paper
• MRI of the hypopharynx, larynx and neck

  1992cites this paper
• Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.

  1992cites this paper
• Vascular evaluation of head and neck masses by magnetic resonance imaging.

  1992cites this paper
• MR imaging of orbital mass lesions with contrast agent: a preliminary report.

  1991cites this paper
• Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging.

  1991cites this paper
• Perineural Extension of Squamous Cell Carcinoma

  1991cites this paper
• Imaging of the nasopharynx.

  1991cites this paper
• Advances in contrast-enhanced MR imaging. Neurologic applications.

  1991cites this paper
• Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck.

  1991cites this paper
• Roles of computed tomography and magnetic resonance imaging diagnoses in the treatment of head and neck cancer.

  1991cites this paper
• Use of gadolinium-enhanced MR imaging for differentiating mucoceles from neoplasms in the paranasal sinuses.

  1991cites this paper
• La risonanza magnetica nella patologia maxillo-facciale

  1991cites this paper
• The impact of radiologic imaging on staging of cancer of the head and neck.

  1991cites this paper
• Gadolinium‐enhanced MRI of tumors of the head and neck

  1990cites this paper
• MRI of the paranasal sinuses and nasal cavity.

  1989cites this paper
• Magnetic Resonance Imaging in Oncology

  1987cites this paper